The regrettable story of the "Covid Kit" and the "Early Treatment of Covid-19" in Brazil
- PMID: 34611650
- PMCID: PMC8484817
- DOI: 10.1016/j.lana.2021.100089
The regrettable story of the "Covid Kit" and the "Early Treatment of Covid-19" in Brazil
Conflict of interest statement
LF has no interests to disclose. BC receives research support from Boehringer-Ingelheim, Amgen, consulting fees from Amgen, Bayer, honoraria for non-promotional speaking from Servier, Boehringer-Ingelheim, and from Elsevier's Order Sets.
Similar articles
-
Regret Me Not: Examining the Relationship between Alcohol Consumption and Regrettable Experiences.Subst Use Misuse. 2020;55(14):2379-2388. doi: 10.1080/10826084.2020.1817084. Epub 2020 Sep 13. Subst Use Misuse. 2020. PMID: 32924717
-
Alcohol Outcome Expectancies and Regrettable Drinking-Related Social Behaviors.Alcohol Alcohol. 2015 Jul;50(4):393-8. doi: 10.1093/alcalc/agv026. Epub 2015 Mar 26. Alcohol Alcohol. 2015. PMID: 25820611 Free PMC article.
-
"Kit-covid" and the Popular Pharmacy Program in Brazil.Cad Saude Publica. 2021 Feb 22;37(2):e00348020. doi: 10.1590/0102-311X00348020. eCollection 2021. Cad Saude Publica. 2021. PMID: 33624699 English, Portuguese. No abstract available.
-
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.Ann Glob Health. 2021 May 18;87(1):44. doi: 10.5334/aogh.3182. Ann Glob Health. 2021. PMID: 34046307 Free PMC article. Review.
-
COVID-19 - 6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced.Diagn Microbiol Infect Dis. 2020 Oct;98(2):115113. doi: 10.1016/j.diagmicrobio.2020.115113. Epub 2020 Jun 15. Diagn Microbiol Infect Dis. 2020. PMID: 32682217 Free PMC article. Review.
Cited by
-
A beta regression analysis of COVID-19 mortality in Brazil.Infect Dis Model. 2023 Jun;8(2):309-317. doi: 10.1016/j.idm.2023.02.005. Epub 2023 Mar 7. Infect Dis Model. 2023. PMID: 36945696 Free PMC article.
-
Emergence of Two Distinct SARS-CoV-2 Gamma Variants and the Rapid Spread of P.1-like-II SARS-CoV-2 during the Second Wave of COVID-19 in Santa Catarina, Southern Brazil.Viruses. 2022 Mar 27;14(4):695. doi: 10.3390/v14040695. Viruses. 2022. PMID: 35458424 Free PMC article.
-
Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines.Rev Saude Publica. 2024 Feb 26;58:06. doi: 10.11606/s1518-8787.2024058005413. eCollection 2024. Rev Saude Publica. 2024. PMID: 38422280 Free PMC article.
-
Lessons From the COVID-19 Pandemic in Latin America: Vulnerability Leading to More Vulnerability.Am J Public Health. 2022 Aug;112(S6):S579-S580. doi: 10.2105/AJPH.2022.306812. Am J Public Health. 2022. PMID: 35977335 Free PMC article. No abstract available.
-
Post-Covid condition and clinic characteristics associated with SARS-CoV-2 infection: a 2-year follow-up to Brazilian cases.Sci Rep. 2023 Aug 26;13(1):13973. doi: 10.1038/s41598-023-40586-8. Sci Rep. 2023. PMID: 37633999 Free PMC article.
References
-
- Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390(10092):415–423. - PubMed
-
- DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19 – First, Do No Harm. JAMA Intern Med. 2020;180(8):1118. - PubMed
-
- Saag MS. Misguided Use of Hydroxychloroquine for COVID-19. JAMA. 2020;324(21):2161. - PubMed
-
- Ventura D, Reis R. An unprecedented attack on human rights in Brazil: the timeline of the federal government's strategy to spread Covid-19. Offprint. Translation by Luis Misiara, revision by Jameson Martins. Bulletin Rights in the Pandemic n. 10, São Paulo, Brazil, CEPEDISA/USP and Conectas Human Rights, January 2021.
Publication types
LinkOut - more resources
Full Text Sources